# A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

> **NCT07454720** · PHASE2,PHASE3 · RECRUITING · sponsor: **Suzhou Suncadia Biopharmaceuticals Co., Ltd.** · enrollment: 165 (estimated)

## Conditions studied

- Locally Advanced Resectable Rectal Cancer

## Interventions

- **DRUG:** Adebrelimab in combination with SHR-8068 and chemotherapy
- **DRUG:** Adebrelimab combined with chemotherapy
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT07454720
- **Lead sponsor:** Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-23
- **Primary completion:** 2032-11
- **Final completion:** 2035-11
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07454720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07454720, "A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07454720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*